Ubs Group Ag Pulmonx Corp Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Pulmonx Corp stock. As of the latest transaction made, Ubs Group Ag holds 83,062 shares of LUNG stock, worth $260,814. This represents 0.0% of its overall portfolio holdings.

Number of Shares

83,062

Previous 201,838 58.85%

Holding current value

$260,814

Previous $1.37 Million 59.2%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$5.68 - $9.22 $674,647 - $1.1 Million	-118,776 Reduced 58.85%	83,062 $559,000
Q4 2024 Feb 14, 2025	BUY	$5.93 - $7.71 $1.07 Million - $1.39 Million	180,665 Added 853.28%	201,838 $1.37 Million
Q3 2024 Nov 14, 2024	SELL	$5.59 - $8.58 $8,172 - $12,543	-1,462 Reduced 6.46%	21,173 $175,000
Q2 2024 Aug 13, 2024	SELL	$5.77 - $9.82 $142,547 - $242,603	-24,705 Reduced 52.19%	22,635 $143,000
Q1 2024 May 13, 2024	BUY	$8.71 - $14.65 $119,022 - $200,192	13,665 Added 40.58%	47,340 $438,000
Q4 2023 Feb 09, 2024	BUY	$7.89 - $13.14 $75,933 - $126,459	9,624 Added 40.01%	33,675 $429,000
Q3 2023 Nov 09, 2023	SELL	$9.88 - $14.0 $21,992 - $31,164	-2,226 Reduced 8.47%	24,051 $248,000
Q2 2023 Aug 11, 2023	SELL	$10.78 - $13.65 $16,148 - $20,447	-1,498 Reduced 5.39%	26,277 $344,000
Q1 2023 May 12, 2023	BUY	$7.49 - $12.54 $112,245 - $187,924	14,986 Added 117.18%	27,775 $310,000
Q4 2022 Feb 08, 2023	SELL	$4.92 - $17.35 $1,923 - $6,783	-391 Reduced 2.97%	12,789 $107,000
Q3 2022 Nov 10, 2022	BUY	$15.35 - $23.99 $71,914 - $112,393	4,685 Added 55.15%	13,180 $220,000
Q2 2022 Aug 10, 2022	SELL	$14.0 - $27.95 $63,532 - $126,837	-4,538 Reduced 34.82%	8,495 $125,000
Q1 2022 May 16, 2022	SELL	$21.13 - $35.65 $45,260 - $76,362	-2,142 Reduced 14.12%	13,033 $324,000
Q4 2021 Feb 14, 2022	BUY	$29.72 - $45.1 $353,519 - $536,464	11,895 Added 362.65%	15,175 $486,000
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $107,939 - $133,440	3,000 Added 1071.43%	3,280 $118,000
Q2 2021 Aug 13, 2021	SELL	$37.61 - $48.0 $159,992 - $204,192	-4,254 Reduced 93.82%	280 $12,000
Q1 2021 May 12, 2021	BUY	$44.0 - $67.54 $108,020 - $165,810	2,455 Added 118.09%	4,534 $207,000
Q4 2020 Feb 11, 2021	BUY	$39.31 - $69.02 $81,725 - $143,492	2,079 New	2,079 $143,000

Others Institutions Holding LUNG

# of Institutions

127

Shares Held

32.5M

Call Options Held

2.6K

Put Options Held

216K

View Full List

About Pulmonx Corp

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $117M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

More about LUNG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account